Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUKE J HALBUR

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1295709996
CMS profile
148783
Location
MESA, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,907.16

133 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,907.16 133

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUKE J HALBUR

NPI 1295709996 · CMS profile ID 148783

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

MESA, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1295709996?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUKE J HALBUR, NPI 1295709996, CMS profile ID 148783. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1295709996?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). LUKE J HALBUR, NPI 1295709996, CMS profile ID 148783. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1295709996?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
LUKE J HALBUR, NPI 1295709996, CMS profile ID 148783, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1295709996?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

133 matching records · $1,907.16 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 133 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 133.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $14.1807/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708571 CMS
Janssen Biotech, Inc. $15.4807/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506427 CMS
PFIZER INC. $14.2607/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949206749 CMS
PFIZER INC. $12.4507/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949200371 CMS
EISAI INC. $22.3806/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908058791 CMS
E.R. Squibb & Sons, L.L.C. $9.6606/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708569 CMS
Janssen Biotech, Inc. $6.0106/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506389 CMS
Amgen Inc. $16.7606/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939844139 CMS
Janssen Biotech, Inc. $4.3906/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506393 CMS
AstraZeneca Pharmaceuticals LP $21.9106/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915863853 CMS
Novartis Pharmaceuticals Corporation $15.8406/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893722993 CMS
Janssen Biotech, Inc. $3.6806/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506419 CMS
E.R. Squibb & Sons, L.L.C. $9.4906/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708565 CMS
PFIZER INC. $12.1106/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949154543 CMS
Gilead Sciences, Inc. $17.0206/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929563211 CMS
Celgene Corporation $6.8605/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708557 CMS
Janssen Biotech, Inc. $8.6905/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506455 CMS
PFIZER INC. $18.9105/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949155335 CMS
Janssen Biotech, Inc. $16.9305/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506461 CMS
GENZYME CORPORATION $22.0905/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938936587 CMS
ABBVIE INC. $21.6405/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892717099 CMS
Celgene Corporation $20.9005/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708549 CMS
E.R. Squibb & Sons, L.L.C. $12.3605/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708551 CMS
Sobi, Inc $13.3105/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940363063 CMS
Merck Sharp & Dohme LLC $17.2805/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944178991 CMS
Novartis Pharmaceuticals Corporation $16.3804/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893722991 CMS
Genentech USA, Inc. $14.6804/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950785739 CMS
E.R. Squibb & Sons, L.L.C. $9.1804/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708539 CMS
Janssen Biotech, Inc. $5.6504/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506415 CMS
Janssen Biotech, Inc. $3.6904/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506411 CMS
Janssen Biotech, Inc. $10.4004/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506439 CMS
Janssen Biotech, Inc. $19.2204/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506369 CMS
Celgene Corporation $17.4604/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708537 CMS
Merck Sharp & Dohme LLC $12.2204/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944142217 CMS
Kite Pharma, Inc. $12.1504/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920059623 CMS
Novartis Pharmaceuticals Corporation $6.8004/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893722987 CMS
Novartis Pharmaceuticals Corporation $20.1204/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893722985 CMS
Novartis Pharmaceuticals Corporation $18.2104/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893722989 CMS
Genentech USA, Inc. $17.3904/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950784605 CMS
PFIZER INC. $14.6404/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949123427 CMS
Genentech USA, Inc. $16.7803/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950786367 CMS
Janssen Biotech, Inc. $3.6803/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506447 CMS
Celgene Corporation $15.1103/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708535 CMS
Merck Sharp & Dohme LLC $17.1803/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944350247 CMS
Daiichi Sankyo Inc. $19.8803/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930809217 CMS
AstraZeneca Pharmaceuticals LP $17.9003/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915488065 CMS
Janssen Biotech, Inc. $2.0803/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506443 CMS
Celgene Corporation $16.7703/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932708527 CMS
Janssen Biotech, Inc. $5.6803/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885506459 CMS
Rigel Pharmaceuticals, Inc. $14.5403/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962270639 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,433.03 86
PY2020 $578.29 34
PY2021 $1,334.64 97
PY2022 $1,907.16 133
PY2023 $1,405.65 73
PY2024 $2,058.63 94
PY2025 $1,483.99 68

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $95,300.39 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $46,207.89 12/09/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228716089
Principal investigator 1 PFIZER INC. $640.00 12/09/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228716091
Principal investigator 1 PFIZER INC. $1,500.00 09/16/2025 Non-covered Recipient Entity
Ironwood Physicians PC
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228752556
Principal investigator 1 PFIZER INC. $22,286.00 08/09/2025 Non-covered Recipient Entity
Ironwood Physicians PC
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228784545
Principal investigator 1 PFIZER INC. $1,128.60 03/31/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228731956
Principal investigator 1 PFIZER INC. $853.20 03/31/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228736281
Principal investigator 1 PFIZER INC. $5,647.61 03/24/2025 Non-covered Recipient Entity
IRONWOOD CANCER RESEARCH CENTERS
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228766881
Principal investigator 1 PFIZER INC. $5,647.61 03/24/2025 Non-covered Recipient Entity
IRONWOOD CANCER RESEARCH CENTERS
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228768476
Principal investigator 1 PFIZER INC. $5,694.74 03/20/2025 Non-covered Recipient Entity
IRONWOOD CANCER RESEARCH CENTERS
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228724984
Principal investigator 1 PFIZER INC. $5,694.74 03/20/2025 Non-covered Recipient Entity
IRONWOOD CANCER RESEARCH CENTERS
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228767473